Skip to content
Disclosery

Maxele Advisors, LLC: COST position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maxele Advisors, LLC on COST, newest first. How the timeline and the estimate are built.

Maxele Advisors, LLC held 1,328 COST shares at 2026-06-30 per its 13F-HR filed 2026-08-17.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,328 shares
    Change vs previous 13F -12 shares

    0.87% of the 13F portfolio, value $1,242,304.

    13F-HR 0002096567-26-000002 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-12-31
    13F 1,340 shares
    Change vs previous 13F -9 shares

    0.94% of the 13F portfolio, value $1,155,536.

    13F-HR 0002096567-26-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 1,349 shares
    Change vs previous 13F +5 shares

    1.08% of the 13F portfolio, value $1,248,675.

    13F-HR 0002096567-25-000001 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 1,344 shares
    Change vs previous 13F +10 shares

    1.16% of the 13F portfolio, value $1,330,479.

    13F-HR 0002096567-25-000008 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 1,334 shares
    Change vs previous 13F +22 shares

    1.22% of the 13F portfolio, value $1,261,671.

    13F-HR 0002096567-25-000007 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-12-31
    13F 1,312 shares
    Change vs previous 13F not available

    1.15% of the 13F portfolio, value $1,202,146.

    13F-HR 0002096567-25-000006 filed by Maxele Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).